©2022 Stanford Medicine
Managing Insulin With a Voice AI
Not Recruiting
Trial ID: NCT05081011
Purpose
This study randomizes participants to have their basal insulin titrated either through
standard of care or by receiving prompts through interactions with an AI-enabled smart
speaker device. The primary objective of this study is to investigate the feasibility of an
AI-enabled smart speaker device and whether such a device facilitates insulin titration
management, increases insulin adherence and decreases time to optimal insulin dose. The
secondary objective of the study is to explore whether the device improves glycemic control
as defined by improvements in fasting blood sugar.
Official Title
Using an AI-based Voice Assistant to Manage Insulin in Diabetes: a Randomized-Control Trial
Stanford Investigator(s)
Kevin Schulman
Professor of Medicine (Hospital Medicine), by courtesy, of Health Policy and of Operations, Information and Technology at the Graduate School of Business
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Eligibility
Inclusion Criteria:
- Patients with Type 2 Diabetes
- Patients clinically indicated to be taking daily long-acting insulin
- Patients currently taking long-acting insulin but necessitating active dose
adjustments
Exclusion Criteria:
- Patients who do not speak English
- Patients who do not own a smart phone
- Patients who do not have stable wireless internet connection at home
Intervention(s):
device: Voice Assistant Device
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Study Team
650-308-8062